134 related articles for article (PubMed ID: 26660162)
1. The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo.
Li WY; Ren JH; Tao NN; Ran LK; Chen X; Zhou HZ; Liu B; Li XS; Huang AL; Chen J
Arch Virol; 2016 Mar; 161(3):621-30. PubMed ID: 26660162
[TBL] [Abstract][Full Text] [Related]
2. AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication
Yu HB; Jiang H; Cheng ST; Hu ZW; Ren JH; Chen J
Int J Med Sci; 2018; 15(12):1356-1364. PubMed ID: 30275764
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1.
Ren JH; Tao Y; Zhang ZZ; Chen WX; Cai XF; Chen K; Ko BC; Song CL; Ran LK; Li WY; Huang AL; Chen J
J Virol; 2014 Mar; 88(5):2442-51. PubMed ID: 24335313
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
5. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.
Xun YH; Zhang YJ; Pan QC; Mao RC; Qin YL; Liu HY; Zhang YM; Yu YS; Tang ZH; Lu MJ; Zang GQ; Zhang JM
J Viral Hepat; 2014 Aug; 21(8):597-603. PubMed ID: 24164660
[TBL] [Abstract][Full Text] [Related]
6. Sodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell lines.
Cheng Z; Zhi X; Sun G; Guo W; Huang Y; Sun W; Tian X; Zhao F; Hu K
J Med Virol; 2016 Apr; 88(4):653-63. PubMed ID: 26331371
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-141 Targets Sirt1 and Inhibits Autophagy to Reduce HBV Replication.
Yang Y; Liu Y; Xue J; Yang Z; Shi Y; Shi Y; Lou G; Wu S; Qi J; Liu W; Wang J; Chen Z
Cell Physiol Biochem; 2017; 41(1):310-322. PubMed ID: 28135713
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway.
Shi Y; Li Y; Huang C; Ying L; Xue J; Wu H; Chen Z; Yang Z
Sci Rep; 2016 Apr; 6():24744. PubMed ID: 27098390
[TBL] [Abstract][Full Text] [Related]
13. The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters.
Tseng YP; Kuo YH; Hu CP; Jeng KS; Janmanchi D; Lin CH; Chou CK; Yeh SF
Antiviral Res; 2008 Mar; 77(3):206-14. PubMed ID: 18249449
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
15. Control of HBV replication by antiviral microRNAs transferred by lentiviral vectors for potential cell and gene therapy approaches.
Kumar M; Follenzi A; Garforth S; Gupta S
Antivir Ther; 2012; 17(3):519-28. PubMed ID: 22300804
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L.
Liu S; Wei W; Li Y; Lin X; Shi K; Cao X; Zhou M
J Ethnopharmacol; 2014 Nov; 157():62-8. PubMed ID: 25260580
[TBL] [Abstract][Full Text] [Related]
17. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes.
Kan Q; Li D; Yu Z
J Virol Methods; 2012 Mar; 180(1-2):84-90. PubMed ID: 22240074
[TBL] [Abstract][Full Text] [Related]
18. Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production.
Ren F; Yang X; Hu ZW; Wong VKW; Xu HY; Ren JH; Zhong S; Jia XJ; Jiang H; Hu JL; Cai XF; Zhang WL; Yao FL; Yu HB; Cheng ST; Zhou HZ; Huang AL; Law BYK; Chen J
EBioMedicine; 2019 Nov; 49():232-246. PubMed ID: 31680002
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, beta-LPA.
He XX; Chen T; Lin JS; Chang Y; Ye BX
Biochem Biophys Res Commun; 2008 May; 369(2):513-8. PubMed ID: 18284916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
